Tag Archives: over

Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »

FDA approves Alzheimer’s drug despite controversy over effectiveness

The Food and Drug Administration has approved the Alzheimer’s drug aducanumab despite controversy over whether there is sufficient evidence to support the drug’s effectiveness. Aducanumab is the first Alzheimer’s drug approved by the FDA in almost 20 years. It has been developed by the company Biogen in collaboration with a Japanese firm Eisai. It is… Read More »

Over 50s to get second doses sooner over fear Indian variant may be 50% more transmissible

Indian variant latest The figures released on Thursday have risen from 520 cases recorded by PHE up to 5 May. Most of the cases have been detected in England, with 1,255 cases recored. There have also been 35 cases detected in Scotland, 12 in Northern Ireland and 11 in Wales, according to PHE. Broken down… Read More »